Adam R Meso

Title: The Innovative Contributions of Adam R Meso

Introduction

Adam R Meso is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of biotechnology, particularly in the development of chimeric clotting factors. His work has the potential to enhance medical treatments related to coagulation disorders.

Latest Patents

Adam R Meso holds a patent for his invention titled "Chimeric clotting factors." This invention provides chimeric clotting factors that comprise an activatable clotting factor and an enhancer moiety. The activatable clotting factor allows the chimeric clotting factor to be activated at the site of coagulation. The enhancer moiety can additionally improve the procoagulation activities of the chimeric clotting factors. Furthermore, the chimeric clotting factors can be improved by fusion to a half-life extender, which enhances the pharmacokinetics properties of the chimeric clotting factor. The invention also includes methods of making and using these chimeric clotting factors. Adam R Meso has 1 patent to his name.

Career Highlights

Adam R Meso is currently employed at Bioverativ Therapeutics Inc., where he continues to innovate in the field of biotechnology. His work focuses on developing advanced therapeutic solutions that can significantly impact patient care.

Collaborations

Throughout his career, Adam has collaborated with talented individuals such as Joe Salas and Elena Kistanova. These collaborations have fostered a creative environment that encourages the development of groundbreaking solutions in the medical field.

Conclusion

Adam R Meso's contributions to the field of biotechnology, particularly through his innovative chimeric clotting factors, demonstrate his commitment to advancing medical science. His work has the potential to improve treatment options for patients with coagulation disorders.